Amreen Husain, MD
Collecting Tumor Samples From Patients With Gynecological Tumors
Contact Information
Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305Brief
RATIONALE: Collecting and storing samples of tumor tissue and blood from patients with cancer to study in the laboratory may help in the study of cancer. PURPOSE: This laboratory study is collecting tumor tissue and blood samples from patients with gynecologic tumors.
Recruiting Status:
RecruitingStanford Recruiting Status:
No longer recruitingCondition(s):
Intervention(s):
- Procedure: phlebotomy
Phase:
N/AEligibility
Ages Eligible for Study:
18 years to Any AgeGenders Eligible for Study:
FemaleHealth of Volunteers:
People with the conditions listed in this trial can participate as controls.Key Inclusion Criteria:
3.11 All patients who have had ovarian tumor tissue removed including all malignant
epithelial tumors, (including papillary serous carcinoma) germ cell, sex cord
stromal and other primary ovarian malignancies. At least one gram of tumor
tissue is required for patients with invasive malignant ovarian epithelial tumors
or ovarian tumors of low malignant potential.
3.12 All patients who have had ovaries removed because of extra-ovarian peritoneal
serous papillary carcinoma.
3.13 All patients who have had ovaries removed prophylactically because of a first or
second degree family member with cancer.
3.14 All patients who have had primary cervical or uterine corpus tumor tissue
removed.
3.15 Patients may have received prior hormonal, cytotoxic chemotherapy, irradiation
or surgical therapy.
Key Exclusion Criteria:
3.21 Patients who do not have primary ovarian tumors, other than those with extraovarian
peritoneal serous papillary carcinomas or those who have had ovaries
removed prophylactically and patients who do not have primary cervical or
uterine corpus tumors.
3.22 Patients with benign cystic tumors of the ovary including cystic epithelial tumors
and mature cystic teratomas.
3.23 Patients not registered on Protocol (through the Statistical Office) within six
weeks after surgery.
3.24 Patients with invasive malignant or low malignant potential ovarian epithelial
tumors with less than one gram of tumor tissue available to submit to the bank.
Note: If tumor has been previously submitted from primary surgery from a patient on Protocol GOG
#152, tumor must be submitted from secondary cytoreduction when available. The method of
submission including the requirement for normal tissue and serum is the same as for any other
136 case. You will receive two additional per capita points for the second submission.
Additional Study Details
Official Title:
Acquisition of Human Gynecologic Specimens to be Used in Studying the Causes, Diagnosis, Prevention and Treatment of CancerAnticipated start date:
10/6/1998Lead Sponsor:
Gynecologic Oncology GroupCollaborator(s):
- NCI
Investigator(s):
- Amreen Husain
- John Chan
- Chad Andrew Hamilton
- Michael Richard Manuel
- Nelson N Teng
Study Type:
ObservationalPurpose:
NOTNEEDEDDuration:
LongitudinalSelection:
Defined PopulationTiming:
RetrospectiveTotal Number to be Enrolled:
750Total Number to be Enrolled at Stanford:
5More Information
Secondary ID(s):
- 75361
- CDR0000078647
- GOG-0136
- GOG136
- NCT00897442
Locations & Contacts
Stanford Locations & Contacts:
Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305Non-Stanford Locations:
This study is being conducted at multiple locations, including non-Stanford locations.
This listing was last updated:
6/17/2009PLEASE NOTE:
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician. If you do not have a primary care physician please feel free to call the SHC Physician Referral Service at (800) 756-9000 or send an email.
Help